IL269893A - - Google Patents
Info
- Publication number
- IL269893A IL269893A IL26989319A IL26989319A IL269893A IL 269893 A IL269893 A IL 269893A IL 26989319 A IL26989319 A IL 26989319A IL 26989319 A IL26989319 A IL 26989319A IL 269893 A IL269893 A IL 269893A
- Authority
- IL
- Israel
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0085—Brain, e.g. brain implants; Spinal cord
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2523/00—Culture process characterised by temperature
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Developmental Biology & Embryology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Virology (AREA)
- General Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762506006P | 2017-05-15 | 2017-05-15 | |
| PCT/IL2018/050523 WO2018211498A1 (en) | 2017-05-15 | 2018-05-14 | Treatment of multiple sclerosis with adipose-derived stem cells |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| IL269893A true IL269893A (https=) | 2019-11-28 |
| IL269893B1 IL269893B1 (en) | 2023-06-01 |
| IL269893B2 IL269893B2 (en) | 2023-10-01 |
Family
ID=64274150
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL269893A IL269893B2 (en) | 2017-05-15 | 2018-05-14 | Treatment of multiple sclerosis with adipose-derived stem cells |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US11510946B2 (https=) |
| EP (1) | EP3624816A4 (https=) |
| JP (1) | JP2020519645A (https=) |
| CN (1) | CN110573170A (https=) |
| AU (1) | AU2018270396B2 (https=) |
| CA (1) | CA3062123A1 (https=) |
| IL (1) | IL269893B2 (https=) |
| WO (1) | WO2018211498A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018211486A1 (en) * | 2017-05-15 | 2018-11-22 | Stem Cell Medicine Ltd. | Treatment of multiple sclerosis with long acting glatiramer and adipose-derived stem cells |
| AU2018270396B2 (en) | 2017-05-15 | 2025-03-20 | Stem Cell Medicine Ltd. | Treatment of multiple sclerosis with adipose-derived stem cells |
| IL272145A (en) | 2020-01-20 | 2021-07-29 | Stem Cell Medicine Ltd | Cosmetic compositions with protein concentrate from conditioned medium of adipose-derived stem cells |
| CN115624571A (zh) * | 2022-12-21 | 2023-01-20 | 北京瑷格干细胞科技有限公司 | 人脂肪间充质干细胞在制备治疗硬皮病药物中的应用 |
| CN115624570A (zh) * | 2022-12-21 | 2023-01-20 | 北京瑷格干细胞科技有限公司 | 人脂肪间充质干细胞在制备治疗结缔组织疾病药物中的应用 |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL36670A (en) | 1971-04-21 | 1974-09-10 | Sela M | Therapeutic basic copolymers of amino acids |
| IL113812A (en) | 1994-05-24 | 2000-06-29 | Yeda Res & Dev | Copolymer-1 pharmaceutical compositions containing it and its use |
| US6214791B1 (en) | 1997-01-10 | 2001-04-10 | Yeda Research And Development Co. Ltd. | Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1 |
| PT1248643E (pt) | 2000-01-20 | 2005-10-31 | Yeda Res & Dev | Utilizacao de copolimero 1 e peptidos e polipeptidos congeneres e de celulas t tratadas co estes compostos para terapia neuroprotectora |
| US8871241B2 (en) | 2002-05-07 | 2014-10-28 | Psivida Us, Inc. | Injectable sustained release delivery devices |
| NZ569331A (en) | 2003-01-21 | 2010-08-27 | Yeda Res & Dev | COP 1 for treatment of inflammatory bowel diseases |
| US7429378B2 (en) | 2003-05-13 | 2008-09-30 | Depuy Spine, Inc. | Transdiscal administration of high affinity anti-MMP inhibitors |
| AU2005308396B2 (en) | 2004-11-29 | 2011-06-09 | Yeda Research And Development Co. Ltd. | Induction of neurogenesis and stem cell therapy in combination with Copolymer 1 |
| WO2006060779A2 (en) | 2004-12-03 | 2006-06-08 | Case Western Reserve University | Novel methods, compositions and devices for inducing neovascularization |
| JP4654015B2 (ja) | 2004-12-08 | 2011-03-16 | 京セラ株式会社 | カメラ装置 |
| US20070003528A1 (en) | 2005-06-29 | 2007-01-04 | Paul Consigny | Intracoronary device and method of use thereof |
| NZ597304A (en) | 2005-10-13 | 2013-06-28 | Anthrogenesis Corp | Immunomodulation using placental stem cells |
| EP1795588A1 (en) | 2005-12-07 | 2007-06-13 | Cellerix, S.L. | Use of adipose tissue derived mesenchymal stem cells for the treatment of graft versus host disease |
| WO2008024996A2 (en) | 2006-08-24 | 2008-02-28 | Johnstone Brian H | Production of neural protective and regenerative factors from stem cells and treatment of nervous system conditions therewith |
| WO2008057443A2 (en) | 2006-11-03 | 2008-05-15 | Multiple Sclerosis Research Center Of New York | Bone marrow-derived mesenchymal stem cells as a source of neural progenitors |
| WO2011041240A1 (en) | 2009-09-30 | 2011-04-07 | The Brigham And Women's Hospital, Inc. | Tissue transplant compositions and methods for use |
| US8703180B1 (en) | 2007-10-23 | 2014-04-22 | Abbott Cardiovascular Systems Inc. | Multiple growth factor compositions, methods of fabrication, and methods of treatment |
| US8481253B2 (en) * | 2008-03-19 | 2013-07-09 | Cryo-Save Ag | Cryopreservation of adipose tissue for the isolation of mesenchymal stem cells |
| US20090291061A1 (en) | 2008-05-21 | 2009-11-26 | Riordan Neil H | Stem cell therapy for blood vessel degeneration |
| EP2620493B1 (en) | 2008-05-28 | 2019-03-27 | Ramot at Tel Aviv University Ltd. | Mesenchymal stem cells for the treatment of CNS diseases |
| US20110129450A1 (en) | 2008-08-01 | 2011-06-02 | Orly Lazarov | Method of promoting neurogenesis by modulating secretase activities |
| WO2010028051A2 (en) | 2008-09-03 | 2010-03-11 | Florida State University Research Foundation, Inc. | Substituted heterocyclic mercaptosulfonamide metalloprotease inhibitors |
| CN102186968A (zh) | 2008-10-17 | 2011-09-14 | 巴克斯特国际公司 | 从脂肪组织获得细胞群的方法 |
| JP5515319B2 (ja) | 2009-02-23 | 2014-06-11 | 富士レビオ株式会社 | 脂肪細胞への分化誘導培地及び方法 |
| CA2767300C (en) | 2009-07-09 | 2020-01-07 | Cellerix Sa | Methods and compositions for use in cellular therapies |
| US8377885B2 (en) | 2010-01-04 | 2013-02-19 | Mapi Pharma Ltd. | Depot systems comprising glatiramer or pharmacologically acceptable salt thereof |
| JP5916622B2 (ja) | 2010-01-04 | 2016-05-11 | マピ ファーマ リミテッド | グラチラマーまたはその薬理学的に許容される塩を含むデポーシステム |
| EP3351625A1 (en) | 2010-02-18 | 2018-07-25 | Osiris Therapeutics, Inc. | Methods of manufacture of immunocompatible amniotic membrane products |
| ES2601892T3 (es) | 2011-04-21 | 2017-02-16 | Mapi Pharma Limited | Pentapolímero aleatorio para el tratamiento de enfermedades autoinmunes |
| US20130034524A1 (en) | 2011-08-03 | 2013-02-07 | Siamak Agha-Mohammadi | Non-Enzymatic Method for Harvesting Adipose-Derived Stromal Cells and Adipose-Derived Stem Cells from Fat and Lipo-Aspirate |
| DK2744892T3 (en) | 2011-09-23 | 2019-04-23 | Cell Ideas Pty Ltd | THERAPEUTICS USING FAT CELLS AND CELL SECRETIONS |
| CL2011002642A1 (es) | 2011-10-24 | 2012-04-09 | Univ Del Desarrollo | Uso de una composicion formada por un glucocorticoide y una tiazolinediona que sirve para inducir la diferenciacion adipogenica en celulas madres. |
| EP2623110A1 (en) | 2012-01-31 | 2013-08-07 | CSL Behring GmbH | Factor XII inhibitors for the treatment of neurological inflammatory disorders |
| EP2825638A4 (en) | 2012-03-12 | 2015-11-25 | Univ Singapore | GENERATION OF BROWN FAT FABRIC FROM MESENCYCLES |
| CN104130975B (zh) * | 2013-05-03 | 2018-07-17 | 上海市东方医院 | 人源脂肪干细胞来源的神经元样细胞及其制备方法和应用 |
| TWI642781B (zh) | 2014-02-06 | 2018-12-01 | 仲恩生醫科技股份有限公司 | 具優異細胞保護及免疫調節之ｑｕａｄｒｉ－正之基質細胞 |
| WO2015120388A1 (en) * | 2014-02-10 | 2015-08-13 | Cytori Therapeutics, Inc. | Regenerative cell therapy for central nervous system (cns) disorders and ptsd |
| CN109072189A (zh) | 2016-02-12 | 2018-12-21 | 细胞治疗药物公司 | 脂肪组织衍生的间充质基质细胞条件培养基及其制备和使用方法 |
| US12161688B2 (en) | 2016-06-30 | 2024-12-10 | Mapi Pharma Ltd | Treatment of inflammatory bowel disease with long acting glatiramer and adipose-derived stem cells |
| AU2018270396B2 (en) | 2017-05-15 | 2025-03-20 | Stem Cell Medicine Ltd. | Treatment of multiple sclerosis with adipose-derived stem cells |
-
2018
- 2018-05-14 AU AU2018270396A patent/AU2018270396B2/en active Active
- 2018-05-14 IL IL269893A patent/IL269893B2/en unknown
- 2018-05-14 CN CN201880028213.1A patent/CN110573170A/zh active Pending
- 2018-05-14 WO PCT/IL2018/050523 patent/WO2018211498A1/en not_active Ceased
- 2018-05-14 CA CA3062123A patent/CA3062123A1/en active Pending
- 2018-05-14 US US16/613,369 patent/US11510946B2/en active Active
- 2018-05-14 JP JP2019562579A patent/JP2020519645A/ja active Pending
- 2018-05-14 EP EP18801976.4A patent/EP3624816A4/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| CA3062123A1 (en) | 2018-11-22 |
| IL269893B2 (en) | 2023-10-01 |
| CN110573170A (zh) | 2019-12-13 |
| AU2018270396B2 (en) | 2025-03-20 |
| EP3624816A4 (en) | 2021-02-24 |
| JP2020519645A (ja) | 2020-07-02 |
| US20200188439A1 (en) | 2020-06-18 |
| AU2018270396A1 (en) | 2020-01-02 |
| WO2018211498A1 (en) | 2018-11-22 |
| US11510946B2 (en) | 2022-11-29 |
| IL269893B1 (en) | 2023-06-01 |
| EP3624816A1 (en) | 2020-03-25 |